Rationale and Design for the Controlled ONset Verapamil INvestigation of Cardiovascular Endpoints (CONVINCE) Trial

This publication has 53 references indexed in Scilit:

• The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
  Archives of internal medicine (1960), 1997
• Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension
  The Lancet, 1997
• Rationale and Design for the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
  American Journal of Hypertension, 1996
• Evaluating the benefits of an antihypertensive agent using trials based on event and organ damage: the Systolic Hypertension in the Elderly Long-term Lacidipine (SHELL) trial and the European Lacidipine Study on Atherosclerosis (ELSA)
  Journal Of Hypertension, 1995
• The E.L.S.A. Trial
  Journal of Cardiovascular Pharmacology, 1994
• Management guidelines in essential hypertension: report of the second working party of the British Hypertension Society.
  BMJ, 1993
• The Fifth Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V)
  Archives of internal medicine (1960), 1993
• STOP-Hypertension 2: A Prospective Intervention Trial of “Newer” versus “Older” Treatment Alternatives in Old Patients with Hypertension
  Blood Pressure, 1993
• The Nordic Diltiazem Study (NORDIL). A Prospective Intervention Trial of of Calcium Antagonist Therapy in Hypertension
  Blood Pressure, 1993
• Blood pressure, stroke, and coronary heart disease: Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context
  Published by Elsevier ,1990